Skip to main navigation
×

Cookie Notification

We use cookies to collect information about how our website is used and to improve the visitor experience. You can change your browser's cookie settings at any time. Please review our privacy policy for more information. OK

This website is intended for a global audience.

Home
  • About Us
    • History & Approach
    • Board of Directors
    • Executive Leadership
    • Company Values & Code of Conduct
    • News
  • Healthcare Professionals
    • Research & Trials
      • Therapeutic Areas
      • CBD Mechanism of Action
      • Cannabinoid Compounds
      • Research Papers
    • Pipeline
    • Epidiolex®
    • Sativex®
      • MS Spasticity
      • Information on Obtaining Sativex®
  • Patient & Caregivers
    • Sativex® Patient Information
  • Investors & Media
    • Financials
      • Financial Reports
      • SEC Filings
      • Stock Information
      • Analyst Coverage
      • Securities in Issue
    • Shareholder Resources
      • Shareholder Services
      • AIM DE-LIST
        • AIM de-list FAQ
        • Conversion of Ordinary shares into ADRs
        • Suggested Broker Contact for conversion of Ordinary Shares to ADRs
      • Shareholder FAQs
      • Contact Us
    • Press Releases
    • Events/Media/Contacts
      • Events & Presentations
      • Advisers
      • IR Contacts
    • Governance
      • Corporate Governance
      • Dislosure Policy
      • Code of Conduct and Business Ethics
      • UK Tax Strategy
  • Careers
    • UK Careers
    • US Careers
  • Contact Us
    • Select a Region
    • European
    • Global Corporate
    • United States (US)
  1. Home
  2. Investors
  3. GW Pharmaceuticals Investor Update Call

Event Details

GW Pharmaceuticals Investor Update Call

Feb 3, 2021 at 8:30 AM EST
Listen to Webcast

Supporting Materials

View Presentation 1.7 MB
  • Email Alerts
  • Downloads
  • RSS Feeds
  • Twitter
  • LinkedIn

  • Home
  • About Us
  • Healthcare Professionals
  • Patients & Caregivers
  • Investors & Media
  • Careers
  • Contact Us
  • Legal

GW Pharmaceuticals plc. All rights reserved